Literature DB >> 22806829

The probiotic Lactobacillus rhamnosus BFE5264 and Lactobacillus plantarum NR74 promote cholesterol efflux and suppress inflammation in THP-1 cells.

Hong-sup Yoon1, Jae-hyun Ju, Ji-eun Lee, Hyun-joon Park, Jung-min Lee, Hyeun-kil Shin, Wilhelm Holzapfel, Kun-young Park, Myoung-Sool Do.   

Abstract

BACKGROUND: The balance between the rate of cholesterol uptake/accumulation and the rate of cholesterol efflux is reflected in the amount of lipid accumulation in macrophages. Based upon the fact that liver X receptors (LXRs) play a role in cholesterol efflux, we studied the effects of probiotics on cholesterol efflux and anti-inflammatory action in macrophages. We confirmed changes in LXR expression by treatment of LXR-transfected CHO-K1 cells with lactic acid bacteria (LAB), and co-cultured THP-1 cells with LAB to investigate changes in cholesterol efflux and inflammation.
RESULTS: The experiment with CHO-K1 cells showed upregulation of LXR-β by LAB. Treatment of THP-1 cells with LAB promoted LXR expression in THP-1, which eventually led to significant upregulation of ABCA1 and ABCG1 expression. The treatment with live LAB also significantly promoted cholesterol efflux. LAB suppressed expression of interleukin (IL)-1β and tumor necrosis factor (TNF)-α, which resulted from activation of LXR.
CONCLUSION: Our study shows that Lactobacillus rhamnosus BFE5264 and Lactobacillus plantarum NR74 activated LXR and induced cholesterol efflux by promoting expression of ABCA1 and ABCG1. Both strains also suppressed proinflammatory cytokines including IL-1β and TNF-α. This study could account for the observation that LAB may block foam cell formation by cholesterol efflux and immune modulation.
© 2012 Society of Chemical Industry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22806829     DOI: 10.1002/jsfa.5797

Source DB:  PubMed          Journal:  J Sci Food Agric        ISSN: 0022-5142            Impact factor:   3.638


  7 in total

1.  Probiotic Bacteria Alter Pattern-Recognition Receptor Expression and Cytokine Profile in a Human Macrophage Model Challenged with Candida albicans and Lipopolysaccharide.

Authors:  Victor H Matsubara; Karin H Ishikawa; Ellen S Ando-Suguimoto; Bruno Bueno-Silva; Atlas E M Nakamae; Marcia P A Mayer
Journal:  Front Microbiol       Date:  2017-11-29       Impact factor: 5.640

2.  Complete Genome Sequence of Lactobacillus rhamnosus BFE5264, Isolated from Maasai Traditional Fermented Milk.

Authors:  Sang-Haeng Choi; Yosep Ji; Soyoung Park; Julius Mathara; Wilhelm Holzapfel; Jihee Kang
Journal:  Genome Announc       Date:  2017-07-06

Review 3.  The regulation of immune cells by Lactobacilli: a potential therapeutic target for anti-atherosclerosis therapy.

Authors:  Ya-Hui Ding; Lin-Yan Qian; Jie Pang; Jing-Yang Lin; Qiang Xu; Li-Hong Wang; Dong-Sheng Huang; Hai Zou
Journal:  Oncotarget       Date:  2017-06-02

Review 4.  Gut microbiota in coronary artery disease: a friend or foe?

Authors:  Bo Zhang; Xinxin Wang; Ran Xia; Chunsheng Li
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

5.  Cholesterol-lowering effect of Lactobacillus rhamnosus BFE5264 and its influence on the gut microbiome and propionate level in a murine model.

Authors:  Soyoung Park; Jihee Kang; Sanghaeng Choi; Haryung Park; Eunchong Hwang; Youn-Goo Kang; Ah-Ram Kim; Wilhelm Holzapfel; Yosep Ji
Journal:  PLoS One       Date:  2018-08-28       Impact factor: 3.240

Review 6.  Lactobacilli and Bifidobacterium as anti-atherosclerotic agents.

Authors:  Milad Abdi; Hadi Esmaeili Gouvarchin Ghaleh; Reza Ranjbar
Journal:  Iran J Basic Med Sci       Date:  2022-08       Impact factor: 2.532

7.  Lactobacillus acidophilus K301 Inhibits Atherogenesis via Induction of 24 (S), 25-Epoxycholesterol-Mediated ABCA1 and ABCG1 Production and Cholesterol Efflux in Macrophages.

Authors:  Yi-Fan Hong; Hangeun Kim; Hye Sun Kim; Woo Jung Park; Joo-Yun Kim; Dae Kyun Chung
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.